Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by broad clinical manifestations including cardiovascular and renal complications with periodic disease flares and significant morbidity and mortality. One of the main contributing factors to the pathology of SLE is th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vojislav Jovanović, Nurhuda Abdul Aziz, Yan Ting Lim, Amanda Ng Ai Poh, Sherlynn Jin Hui Chan, Eliza Ho Xin Pei, Fei Chuin Lew, Guanghou Shui, Andrew M Jenner, Li Bowen, Eoin F McKinney, Paul A Lyons, Michael D Kemeny, Kenneth G C Smith, Markus R Wenk, Paul A Macary
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e9d92f41f9d141d2bcea8a5d77b6f715
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e9d92f41f9d141d2bcea8a5d77b6f715
record_format dspace
spelling oai:doaj.org-article:e9d92f41f9d141d2bcea8a5d77b6f7152021-11-18T07:58:21ZLipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.1932-620310.1371/journal.pone.0055639https://doaj.org/article/e9d92f41f9d141d2bcea8a5d77b6f7152013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23409013/?tool=EBIhttps://doaj.org/toc/1932-6203Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by broad clinical manifestations including cardiovascular and renal complications with periodic disease flares and significant morbidity and mortality. One of the main contributing factors to the pathology of SLE is the accumulation and impaired clearance of immune complexes of which the principle components are host auto-antigens and antibodies. The contribution of host lipids to the formation of these autoimmune complexes remains poorly defined. The aim of the present study was to identify and analyze candidate lipid autoantigens and their corresponding anti-lipid antibody responses in a well-defined SLE patient cohort using a combination of immunological and biophysical techniques. Disease monitoring in the SLE cohort was undertaken with serial British Isles Lupus Assessment Group (BILAG) scoring. Correlations between specific lipid/anti-lipid responses were investigated as disease activity developed from active flares to quiescent during a follow up period. We report a significant negative correlation between anti-lipid antibodies for 24S-hydroxycholesterol, cardiolipin and phosphatidylserine with SLE disease activity. Taken together, these data suggest that lipid autoantigens represent a new family of biomarkers that can be employed to monitor disease activity plus the efficacy of therapeutic intervention in SLE.Vojislav JovanovićNurhuda Abdul AzizYan Ting LimAmanda Ng Ai PohSherlynn Jin Hui ChanEliza Ho Xin PeiFei Chuin LewGuanghou ShuiAndrew M JennerLi BowenEoin F McKinneyPaul A LyonsMichael D KemenyKenneth G C SmithMarkus R WenkPaul A MacaryPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 2, p e55639 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Vojislav Jovanović
Nurhuda Abdul Aziz
Yan Ting Lim
Amanda Ng Ai Poh
Sherlynn Jin Hui Chan
Eliza Ho Xin Pei
Fei Chuin Lew
Guanghou Shui
Andrew M Jenner
Li Bowen
Eoin F McKinney
Paul A Lyons
Michael D Kemeny
Kenneth G C Smith
Markus R Wenk
Paul A Macary
Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
description Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by broad clinical manifestations including cardiovascular and renal complications with periodic disease flares and significant morbidity and mortality. One of the main contributing factors to the pathology of SLE is the accumulation and impaired clearance of immune complexes of which the principle components are host auto-antigens and antibodies. The contribution of host lipids to the formation of these autoimmune complexes remains poorly defined. The aim of the present study was to identify and analyze candidate lipid autoantigens and their corresponding anti-lipid antibody responses in a well-defined SLE patient cohort using a combination of immunological and biophysical techniques. Disease monitoring in the SLE cohort was undertaken with serial British Isles Lupus Assessment Group (BILAG) scoring. Correlations between specific lipid/anti-lipid responses were investigated as disease activity developed from active flares to quiescent during a follow up period. We report a significant negative correlation between anti-lipid antibodies for 24S-hydroxycholesterol, cardiolipin and phosphatidylserine with SLE disease activity. Taken together, these data suggest that lipid autoantigens represent a new family of biomarkers that can be employed to monitor disease activity plus the efficacy of therapeutic intervention in SLE.
format article
author Vojislav Jovanović
Nurhuda Abdul Aziz
Yan Ting Lim
Amanda Ng Ai Poh
Sherlynn Jin Hui Chan
Eliza Ho Xin Pei
Fei Chuin Lew
Guanghou Shui
Andrew M Jenner
Li Bowen
Eoin F McKinney
Paul A Lyons
Michael D Kemeny
Kenneth G C Smith
Markus R Wenk
Paul A Macary
author_facet Vojislav Jovanović
Nurhuda Abdul Aziz
Yan Ting Lim
Amanda Ng Ai Poh
Sherlynn Jin Hui Chan
Eliza Ho Xin Pei
Fei Chuin Lew
Guanghou Shui
Andrew M Jenner
Li Bowen
Eoin F McKinney
Paul A Lyons
Michael D Kemeny
Kenneth G C Smith
Markus R Wenk
Paul A Macary
author_sort Vojislav Jovanović
title Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
title_short Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
title_full Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
title_fullStr Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
title_full_unstemmed Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
title_sort lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/e9d92f41f9d141d2bcea8a5d77b6f715
work_keys_str_mv AT vojislavjovanovic lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT nurhudaabdulaziz lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT yantinglim lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT amandangaipoh lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT sherlynnjinhuichan lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT elizahoxinpei lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT feichuinlew lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT guanghoushui lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT andrewmjenner lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT libowen lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT eoinfmckinney lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT paulalyons lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT michaeldkemeny lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT kennethgcsmith lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT markusrwenk lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
AT paulamacary lipidantilipidantibodyresponsescorrelatewithdiseaseactivityinsystemiclupuserythematosus
_version_ 1718422702132297728